10Indexed trials
mesh condition
Tobacco Use Disorder
Intelligence
Tobacco Use Disorder intelligence: 10 indexed trials, 1 recruiting studies, 10 sponsors across 3 countries.
1Recruiting
10Sponsors
3Countries
Leading sponsors
Duke University10 recruiting
Mark Vander Weg10 recruiting
Massachusetts General Hospital10 recruiting
Medical University of South Carolina10 recruiting
Sahlgrenska University Hospital10 recruiting
Sigmund Freud PrivatUniversitat11 recruiting
University of California, Los Angeles10 recruiting
University of Missouri-Columbia10 recruiting
University of Pennsylvania10 recruiting
Xingbao Li10 recruiting
Geographic activity
United States8trials
Austria1trials
Sweden1trials
Leading interventions
ABT-0891trials
Alcohol use risk reduction1trials
Behavioral activation for depressive symptoms1trials
Behavioral management of postcessation weight gain1trials
Bupropion1trials
Combination pharmacotherapy - Transdermal nicotine patch + bupropion1trials
Combination pharmacotherapy - Transdermal nicotine patch + nicotine gum1trials
Combination pharmacotherapy - Transdermal nicotine patch + nicotine lozenge1trials
Continuous Theta-burst stimulation (cTBS)1trials
Control1trials
Integrated cognitive-behavioral therapy for smoking cessation and anxiety1trials
6-weeks CBT smoking cessation programme1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.